|
Mark McDade has been Chief Executive Officer and a Director of PDL BioPharma since November 2002. Before joining PDL BioPharma, he served as Chief Executive Officer of Signature BioScience, Inc. from December 2000 until November 2002. Mr. McDade was previously a co-founder and director of Corixa Corporation, where he served as Chief Operating Officer from September 1994 through December 1998 and as President and Chief Operating Officer from January 1999 until his departure in late 2000. Before Corixa, Mr. McDade was Chief Operating Officer of Boehringer Mannheim Therapeutics, and prior to that held several positions at Sandoz Ltd. including business development, product management and general management. Mr. McDade currently serves on the boards of directors of Valentis, Inc. and Cytokinetics, Inc. He received a B.A. from Dartmouth College and an M.B.A. from Harvard Business School.
| 